cannabidiol/aspatame (JW-200) / Jupiter Wellness - LARVOL DELTA

Jupiter Wellness Advances Clinical Pipeline of CBD-Based Topical Treatments (Issuer Direct) - “Jupiter Wellness…announced an update on its clinical pipeline of CBD-based therapeutic topical formulations…JW-200 for skin cancer…The objective of this double blinded, placebo-controlled study is to evaluate the efficacy of JW-200 in both the treatment and prevention of disease, with a primary efficacy endpoint of the percentage of patients with complete clearance of AK lesions. An estimated 120 adults diagnosed with AK will be recruited, with an expected study completion date of Q4 2021.”

Pipeline update • Oncology • Skin Cancer